Publicaciones
- ÁREA TERAPÉUTICA VIH Y SIDA
Estrada V, Górgolas M, Peña JA, Tortajada E, Castro A, Presa M, Oyagüez I
Epidemiologic and economic analysis of rapid antiretroviral therapy initiation with bictegravir/emtricitabine/tenofovir alafenamide in Spain
PharmacoEconomics - Open https://doi.org/10.1007/s41669-022-00322-w
Moltó J, González J, Navarro C, Castro A, Presa M, Oyagüez I
Cribado dirigido del Virus de la Inmunodeficiencia Humana en los servicios de urgencias en España: análisis de las consecuencias epidemiológicas y económicas
Emergencias 2022;34:21-28
Moltó J, González J, Navarro C, Presa M, Casado MA
Epidemiologic and economic analysis of targeted screening for human immunodeficiency virus in emergency department in Spain
Congress International Health Economics Association (IHEA). 12-15 jul 2021
Estrada V, Górgolas M, Peña JA, Tortajada E, Presa M, Casado MA
Epidemiologic and economic analysis of early antiretroviral therapy with bictegravir/embtricitabine/tenofovir alafenamide in Spain
Congress International Health Economics Association (IHEA). 12-15 jul 2021
Coll P, Jarrín I, Martínez E, Martínez-Sesmero JM, Domínguez-Hernández R, Casado MA
Achieving 2030 UNAIDS goals in human immunodeficiency virus individuals: a simulation model to prioritize interventions for decision making
23th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Virtual. 16-19 nov 2020
Podzamczer D, Rozas N, Domingo P, Miralles C, den Eynde EV, Romero A, Deig E, Knobel H, Pasquau J, Antela A, Clotet B, Geijo P, de Castro ER, Casado MA, Muñoz A, Casado A
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to CART. PRO-STR Study
Current HIV Research, 2018, 16, 425-435
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to RPV/FTC/TDF due to intolerance to previous cART: the PRO-STR study
Journal Antimicrobial Chemotherapy.Doi: 10.1093/jac/dky175
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Castaño M, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Podzamczer D
Lipid Changes And Tolerability In A Cohort Of Adult HIV-infected Patients Switching To RPV/FTC/TDF, Due To Intolerance To Previous cART. A Substudy Of PRO-STR Study.
VII Congreso Nacional de Gesida. Madrid, Spain. 1-4 dic 2015.
Podzamczer D, Rozas N, Domingo P, Ocampo A,Van den Eynde E, Vergara A, Deig E, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Geijo P, Rodríguez de Castro E, Casado A
Clinical Data And Patient-Reported Outcomes (PRO) In HIV-Infected Adults Switching To RPV/FTC/TDF, Due To A Previous Intolerance To cART. Interim Analysis Of The PRO-STR Study.
VII Congreso Nacional de Gesida. Madrid, Spain. 1-4 dic 2015.
Podzamczer D, Rozas N, Domingo P, Ocampo A,Van den Eynde E, Vergara A, Deig E, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Geijo P, Rodríguez de Castro E, Casado A
Clinical Data And Patient-Reported Outcomes (PRO) In HIV-Infected Adults Switching To RPV/FTC/TDF, Due To A Previous Intolerance To cART. Interim Analysis Of The PRO-STR Study.
15th European AIDS Conference (EACS). Barcelona, Spain. 21-24 oct 2015.
Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Castaño M, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Podzamczer D
Lipid Changes And Tolerability In A Cohort Of Adult HIV-infected Patients Switching To RPV/FTC/TDF, Due To Intolerance To Previous cART. A Substudy Of PRO-STR Study.
15th European AIDS Conference (EACS). Barcelona, Spain. 21-24 oct 2015.
Ventura Cerdá JM, Martín Conde MT, Morillo Verdugo R, Yébenes Cortés M, Casado Gómez MA
Farm Hosp. 2014;38(4):291-9.
Pérez-Valero I, Martín-Quirós A, Roldán C, Díaz M, Torres C, Bernardino JI, Zamora FX, Pascual F, Arribas JR, González L, Herrero A, Casado MA, De La Puente M, González-Garcia J
Estudio de Coste-Efectividad de las estrategias terapéuticas actuales de simplificación del tratamiento antrirretroviral-Estudio Gesida 6911.
V Congreso Nacional GeSIDA. Sitges, España. 19-22 nov 2013.
Homar F, Lozano V, Oyagüez I, Casado MA
Cost analysis of antiretroviral treatment and drug-related adverse events of fixed-dose combinations of antiretrovirals versus separate components in HIV-1 therapy.
17th Congress of European Association of Hospital Pharmacist (EAHP). Milan, Italy. 21-23 mar 2012.
Homar F, Lozano V, Martínez-Gómez J, Oyagüez I, Pareja A, Payeras A, Serrano J, Carmen Carratalá, Casado MA
Health Econ Rev. 2012,2:16.
Moreno S, González J, Lekander I, Martí B, Oyagüez I, Sánchez-de la Rosa R, Casado MA
Clin Therap. 2010;32(13):2232-45.
Oyagüez I, Casado MA, Cotarelo M, Ramírez-Arellano A, Mallolas J.
Farm Hosp. 2009;33:247-56.
Ventura JM, Casado MA, Escobar I, Ibarra O, Ortega L, Morales JM, Cotarelo M
Preferencias, satisfacción y adherencia con el tratamiento antirretroviral. Estudio ARPAS (II).
Farm Hosp. 2007;31:340-5.2
Ventura JM, Casado MA, Morales JM, Ortega L, Ibarra O, Escobar I
Farm Hosp. 2007;31:331-9.
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Herrera L, Sánchez-de la Rosa R
Pharmacoeconomics Span Res Art. 2007;4:25-36.
Libre Codina JM, Casado Gómez MA, Sanchez-de la Rosa R, Pérez-Elías MJ, Santos González J, Miralles álvarez C, Martínez Chamorro E, Domingo Pedrol P, Alvarez García ML, Moreno Guillen S
Costes de la toxicidad asociada a los análogos de nucleósidos inhibidores de la transcriptasa inversa en pacientes con infección por el VIH-1.
Enferm Infec Microbiol Clin. 2007;25:98-107.
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Alvarez ML
Tenofovir DF is associated with decreased HIV-related healthcare costs in HIV-1-infected heavily pre-treated patients with nucleoside reverse transcriptase inhibitors-related toxicity.
10th European AIDS Conference / EACS. Dublin, Ireland. 17-20 nov 2005.
Moreno S, Casado MA, Domingo P, Llibre JM, Martínez E, Miralles C, Santos J, Pérez-Elías MJ, Sánchez de la Rosa R
Cost of the NRTI-related toxicities in HIV-1-infected heavily experienced patients.
7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Dublin, Ireland. 13-16 nov 2005.